Company profile
Ticker
KVUE
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
JNTL, Inc.
SEC CIK
Corporate docs
Subsidiaries
Beijing Dabao Cosmetics Co., Ltd. • Carlo Erba OTC S.r.l. • Ci:z. Labo Co., Ltd. • Debs-Vogue Corporation (Proprietary) Limited • JNTL (APAC) HoldCo 2 LLC • JNTL (APAC) HoldCo 3 Pte. Ltd. • JNTL (APAC) HoldCo LLC • JNTL (APAC) HoldCo Pte. Ltd. • JNTL (Canada) HoldCo ULC • JNTL (Japan) HoldCo Inc. ...
IRS number
881032011
KVUE stock data
Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
10 Apr 24
DEFA14A
Additional proxy soliciting materials
10 Apr 24
DEF 14A
Definitive proxy
10 Apr 24
10-K
2023 FY
Annual report
1 Mar 24
8-K
Kenvue Reports Full Year and Fourth Quarter 2023 Results
8 Feb 24
8-K
Departure of Directors or Certain Officers
5 Dec 23
8-K
Other Events
17 Nov 23
10-Q
2023 Q3
Quarterly report
3 Nov 23
8-K
Kenvue Reports Healthy Third Quarter 2023 Results
26 Oct 23
EFFECT
Notice of effectiveness
19 Sep 23
Financial summary
Quarter (USD) | Oct 23 | Jul 23 | Apr 23 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | |||
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.06 bn | 1.06 bn | 1.06 bn | |||
Cash burn (monthly) | 56.33 mm | (no burn) | (no burn) | |||
Cash used (since last report) | 388.07 mm | n/a | n/a | |||
Cash remaining | 673.93 mm | n/a | n/a | |||
Runway (months of cash) | 12.0 | n/a | n/a |
Institutional ownership, Q4 2023
75.6% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 784 |
Opened positions | 147 |
Closed positions | 254 |
Increased positions | 332 |
Reduced positions | 234 |
13F shares | Current |
---|---|
Total value | 24.00 tn |
Total shares | 1.45 bn |
Total puts | 16.87 mm |
Total calls | 32.80 mm |
Total put/call ratio | 0.5 |
Largest owners | Shares | Value |
---|---|---|
JNJ Johnson & Johnson | 182.33 mm | $0.00 |
Vanguard | 148.88 mm | $3.21 tn |
FMR | 110.93 mm | $2.39 tn |
T. Rowe Price | 109.33 mm | $2.35 bn |
STT State Street | 99.40 mm | $2.14 tn |
Wellington Management | 76.50 mm | $1.65 tn |
Massachusetts Financial Services | 66.67 mm | $1.44 tn |
JPM JPMorgan Chase & Co. | 60.24 mm | $1.30 tn |
MS Morgan Stanley | 35.26 mm | $759.25 bn |
BK Bank Of New York Mellon | 32.46 mm | $698.85 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Apr 24 | Allison Richard E JR | Deferred Share Units Common Stock | Grant | Acquire A | No | No | 19.14 | 1,306 | 25.00 k | 9,156.564 |
5 Mar 24 | Thibaut Mongon | Stock Options Common Stock | Grant | Acquire A | No | No | 19.01 | 857,649 | 16.30 mm | 857,649 |
5 Mar 24 | Thibaut Mongon | RSU Common Stock | Grant | Acquire A | No | No | 0 | 95,344 | 0.00 | 95,344 |
5 Mar 24 | Carlton Lawson | Stock Options Common Stock | Grant | Acquire A | No | No | 19.01 | 193,059 | 3.67 mm | 193,059 |
5 Mar 24 | Carlton Lawson | RSU Common Stock | Grant | Acquire A | No | No | 0 | 21,462 | 0.00 | 21,462 |
5 Mar 24 | Matthew Orlando | Stock Options Common Stock | Grant | Acquire A | No | No | 19.01 | 160,481 | 3.05 mm | 160,481 |
5 Mar 24 | Matthew Orlando | RSU Common Stock | Grant | Acquire A | No | No | 0 | 17,840 | 0.00 | 17,840 |
5 Mar 24 | Jan Meurer | Stock Options Common Stock | Grant | Acquire A | No | No | 19.01 | 179,810 | 3.42 mm | 179,810 |
5 Mar 24 | Jan Meurer | RSU Common Stock | Grant | Acquire A | No | No | 0 | 19,989 | 0.00 | 19,989 |
News
Looking Into Kenvue's Recent Short Interest
24 Apr 24
Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert (Updated)
23 Apr 24
Bernstein Initiates Coverage On Kenvue with Underperform Rating, Announces Price Target of $18
11 Apr 24
Beyond The Numbers: 5 Analysts Discuss Kenvue Stock
3 Apr 24
William Blair Initiates Coverage On Kenvue with Market Perform Rating
3 Apr 24
Press releases
Kenvue Declares Quarterly Cash Dividend
25 Apr 24
Illinois Jury Awards $45 Million in Mesothelioma Case Against Johnson & Johnson, Kenvue, Inc.
19 Apr 24
Kenvue to Showcase 22 New Sets of Clinical Data at American Academy of Dermatology Association Meeting
7 Mar 24
Kenvue to Present at the Consumer Analyst Group of New York Conference on February 23, 2024
13 Feb 24
Kenvue Reports Full Year and Fourth Quarter 2023 Results
8 Feb 24